INMD240920P21000
- 3.99
- 0.000.00%
InMode Newsroom
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
Are Investors Undervaluing InMode (INMD) Right Now?
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday
InMode announces share repurchase plan to repurchase up to 7.68 million shares
InMode announces 7.68 million share repurchase plan
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
InMode Announces Share Repurchase Program Of Up To 7.68 Million Shares >INMD
InMode Ltd. (NASDAQ:INMD) Institutional Owners May Be Pleased With Recent Gains After 58% Loss Over the Past Year
CORRECTTION: InMed Ticker Is 'INM'
InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease
InMode Ltd. (INMD): Challenges and Insights in the Beauty Industry
Hartwater Aesthetics to Present at Upcoming Industry Conference
InMode to Present at Upcoming Investor Conferences
InMode's Resilience Amidst Challenges: A Buy Rating With a Positive Outlook on Upcoming Product Launches and Market Recovery
InMode Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Hartwater Aesthetics to Unveil the Next Generation of Morpheus8
InMode's (NASDAQ:INMD) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Navigating InMode's Challenges: A Cautious Hold Rating Amidst Macroeconomic and Operational Hurdles
Express News | Inmode Ltd : Jefferies Cuts Target Price to $18 From $19
InMode (INMD) Q2 2024 Earnings Call Transcript
Needham Maintains InMode(INMD.US) With Hold Rating
Needham analyst Michael Matson maintains $InMode(INMD.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 44.5% and a total average return of -4.6% over the past